|
|
Correlations between peripheral blood C-reactive protein, lymphocyte and pneumonia severity indexes in patients with influenza |
ZHANG Weichen, PEI Yufang |
Department of Preventive Health Service,Qinhuangdao First Hospital,Qinhuangdao 066000,China |
|
|
Abstract Objective To analyze the correlations between peripheral blood C-reactive protein, lymphocytes and the pneumonia severity index in patients with influenza. Methods The 66 patients who were treated at our hospital between January 2019 and April 2019 were selected, whose clinical data such as sex, age, height, weight, smoking history, drinking history, onset time of fever, influenza type, blood routine test and pneumonia severity index was analyzed retrospectively. These cases were divided into the severe influenza group and mild influenza group based on the severity of disease. Single factor analysis was carried out on the demographic and clinical characteristics of the two groups to identify the influencing factors of severe pneumonia. Spearman correlation and linear regression were used to analyze the correlations between C-reactive protein, lymphocytes and the pneumonia severity index. Results The leukocyte count, platelet count, lymphocyte absolute value, lymphocyte percentage and monocyte absolute value in the severe influenza group were significantly lower than those in the mild influenza group, while the C-reactive protein level and pneumonia severity index were significantly higher (P< 0.05). The absolute value of lymphocytes was negatively correlated with the severity index and lymphocyte percentage of pneumonia (r=-0.6850, P<0.001), while C-reactive protein was positively correlated with the severity index of pneumonia (r=0.8523, P<0.001). Conclusions The decrease of lymphocytes, increase of C-reactive protein and pneumonia severity index are risk factors for severe influenza. C-reactive protein is positively correlated with the pneumonia severity index, which is negatively correlated with lymphocytes.
|
Received: 20 December 2019
|
|
|
|
|
[1] |
陈 英.儿童 A 型流感和 B 型流感的临床特征分析[J]. 武警医学, 2018, 29(1): 42-44.
|
[2] |
靳玉瑞,康家雄,李爱秀. 流感病毒神经氨酸酶抑制药的药理作用与临床应用[J]. 武警医学, 2019, 30(6): 537-540.
|
[3] |
武涧松,原 杰,贺婷婷,等.流感暴发期间5447例成人流感样病例的流感病毒检测结果与分布特征[J]. 中华医院感染学杂志,2018,29(23):3521-3526.
|
[4] |
张美义,何家靖,杨子峰,等.金翘片体内抗甲型H3N2流感病毒及禽流感病毒H9N2作用研究[J]. 广州中医药大学学报,2019,36(7):1064-1068.
|
[5] |
刘道利,龙华婧,夏 阳,等.甲型和乙型流感患者白细胞分类比较及临床特征分析[J]. 国际检验医学杂志,2017,38(13):1740-1742.
|
[6] |
陈 亮,韩秀迪,邢西迁,等.甲型流感社区获得性肺炎死亡风险预测模型的建立[J].中国呼吸与危重监护杂志,2018,17(5):445-449.
|
[7] |
李 明,苏 维,马士恒,等.甲型 H1N1 型流感患者外周血程序化细胞死亡分子 5表达水平及其与疾病严重程度的相关性[J].医学研究生学报,2018,31(6):636-640.
|
[8] |
孟 欣,胡辽辽,张 宁,等.中性粒细胞/淋巴细胞比值在甲、乙型流感病毒感染患者预测价值分析[J].国际检验医学杂志,2019,40(20):2464-2467.
|
[9] |
任书华.人口流动强度与甲型 H1N1 流感和人感染 H7N9禽流感流行的相关性研究[J]. 现代预防医学,2018,45(3):537-543.
|
[10] |
刘秀红,赵一鸣,李 莉,等.甲型 H1N1流感住院患者病毒核酸与淋巴细胞百分比的相关性分析[J]. 中国实验诊断学,2015,19(10):1717-1722.
|
[11] |
Haran J P,Suner S,Gardiner F,et al. Correlation of C-reactive protein to severity of symptoms in acute influenza ainfection [J].J Emerg Trauma Shock, 2012,5(2):149-152.
|
[12] |
Cheng Y,Zhao H,Song P,et al. Dynamic changes of lymphocyte counts in adult patients with severe pandemic H1N1 influenza A[J].J Infect Public Health, 2019, 12 (6):878-883.
|
[13] |
Xiang L,Zhou T J,Zhou L L,et al. Influenza a virus and Streptococcus pneumonia coinfection potentially promotes bacterial colonization and enhances B lymphocyte depression and reduction [J]. J Biol Regul Homeost Agents,2019,33(5):1437-1449.
|
[14] |
Wu Y,Tu W,Lam K T. Lethal coinfection of influenza virus and streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph node [J].J Virol,2015,89(4):2013-2023.
|
[15] |
Cunha B A,Connolly J J,Irshad N. The clinical usefulness of lymphocyte: monocyte ratios in differentiating influenza from viral non-influenza-like illnesses in hospitalized adults during the 2015 influenza A (H3N2) epidemic: the uniqueness of HPIV-3 mimicking influenza A[J]. Eur J Clin Microbiol Infect Dis, 2016,35(1):155-158.
|
|
|
|